Yutaka Wakemi
Corporate Officer/Principal bei SUMITOMO PHARMA CO., LTD.
Ursprung des Netzwerks ersten Grades von Yutaka Wakemi
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Yutaka Wakemi
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| TOKYU FUDOSAN HOLDINGS CORPORATION | Real Estate Development | Director/Board Member | |
| IHI CORPORATION | Industrial Machinery | Director/Board Member | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member | |
| Hiroshima University | College/University | Doctorate Degree | |
Meltin MMI KK
 Meltin MMI KK Medical SpecialtiesHealth Technology Meltin MMI KK develops bio-signal interface technologies. It offers biosignal processing and cable-driven ststems. The company was founded by Sumio Ito, Masahoro Kasuya and Tatsuya Seki and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Financial Services Agency | General Government | Corporate Officer/Principal | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member | |
Primetals Technologies Ltd.
 Primetals Technologies Ltd. Information Technology ServicesTechnology Services Primetals Technologies Ltd. operates as a engineering and plant construction company. It manures of steel and iron products. The company was founded in January 2015 and is headquartered in London, the United Kingdom. | Information Technology Services | Director of Finance/CFO | |
| SEIKO EPSON CORPORATION | Computer Peripherals | Chairman | |
| KIKKOMAN CORPORATION | Food: Specialty/Candy | Director/Board Member | |
| TOKIO MARINE HOLDINGS, INC. | Property/Casualty Insurance | Director/Board Member | |
| JAPAN EXCHANGE GROUP, INC. | Investment Banks/Brokers | Director/Board Member | |
| SEIKO GROUP CORPORATION | Other Consumer Specialties | Director/Board Member | |
NEC Asia Pacific Pte Ltd.
 NEC Asia Pacific Pte Ltd. Information Technology ServicesTechnology Services NEC Asia Pacific Pte Ltd. provides computer software solutions. Its solutions and services include digital signage, ERP, infrastructure, managed services and outsourcing, RFID, public safety solutions and services, unified communications and virtual PC center. The company was founded in 1977 and is headquartered in Singapore. | Information Technology Services | Chairman | |
| JAPAN POST INSURANCE CO., LTD. | Life/Health Insurance | Director/Board Member | |
| Tokyo Institute of Technology | College/University | Doctorate Degree | |
| RENESAS ELECTRONICS CORPORATION | Semiconductors | Director/Board Member | |
| NEC CORPORATION | Information Technology Services | Chairman | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member |
Statistik
International
| Japan | 16 |
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 4 |
| Singapur | 2 |
Sektoral
| Health Technology | 8 |
| Finance | 5 |
| Technology Services | 4 |
| Electronic Technology | 4 |
| Consumer Services | 3 |
Operativ
| Director/Board Member | 28 |
| Corporate Officer/Principal | 15 |
| Independent Dir/Board Member | 10 |
| Chief Tech/Sci/R&D Officer | 4 |
| Chairman | 3 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Yutaka Wakemi
- Unternehmensverbindungen
